Filing Details
- Accession Number:
- 0001209191-18-048223
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-23 17:11:11
- Reporting Period:
- 2018-08-21
- Accepted Time:
- 2018-08-23 17:11:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1016169 | Antares Pharma Inc. | ATRS | Surgical & Medical Instruments & Apparatus (3841) | 411350192 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1054942 | F Robert Apple | C/O Antares Pharma, Inc. 100 Princeton South, Suite 300 Ewing NJ 08628 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-21 | 43,000 | $0.47 | 1,573,562 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-21 | 43,000 | $3.75 | 1,530,562 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-08-21 | 43,000 | $0.00 | 43,000 | $0.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-11-11 | No | 4 | M | Direct |
Footnotes
- The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. The exercised stock options reported on this Form 4 were due to expire on November 11, 2018.
- The options vested and became exercisable in equal quarterly installments over three years following the grant date of November 12, 2008.
Billionaire Hedge Funds
